Seriously, what were you expecting?
Every biotech company listed globally on a stock exchange gets a free pass to be valued using any kind of fairy metric it wants regardless of quality?
Could fall over tomorrow but it's ok because we can rely on fairy numbers to continue throwing good money after bad. Brilliant.